Abstract
The renin-angiotensin system (RAS) has become increasingly complex. New components have been identified, and additional roles for angiotensin peptides and their receptors are being uncovered. A functional (pro)renin receptor has been cloned that acts as (pro)renin cofactor on cell surface, enhancing the efficiency of angiotensinogen cleavage by (pro)renin and unmasking prorenin catalytic activity. Binding of (pro)renin to the receptor mediates (pro)renin cellular effects by activating mitogen-activating protein (MAP) kinases, extracellular signal-regulated kinases (ERK)1/2. Immunofluorescence studies have localized the receptor on mesangial and vascular smooth muscle cells in human heart and kidney. This suggests that the renin receptor might represent a means to capture (pro)renin from the circulation and to concentrate (pro)renin at the interface between smooth muscle and endothelial cells. In this article, we review the biochemical characteristics of this receptor and of other renin-binding proteins, and discuss their physiologic significance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Nguyen G, Delarue F, Burckle C, et al.: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417–1427. This paper reports the cloning of a functional receptor of renin and describes the characteristics of renin binding (activation of MAP kinases, ERK1/2, and the co-factor activity of the receptor). The localization of the receptor on vascular smooth muscle cells and mesangial cells and its co-localization with renin are described.
Albitson AL, McDowall SG, Matsacos D, et al.: Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001, 276:48623–48626.
Dzau VJ, Bernstein K, Celermajer D, et al.: The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001, 88(Suppl):1L-20L.
Schuijt MP, de Vries R, Saxena PR, et al.: Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br J Pharmacol 2002, 135:275–283.
Dell’Italia LJ, Meng QC, Balcells E, et al.: Compartimentalisation of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial space. J Clin Invest 1997, 100:253–258.
Nguyen G, Delarue F, Berrou J, et al.: Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996, 50:1897–1903.
Saris JJ, Derkx FHM, de Bruin RJA, et al.: High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol 2001, H1706–H1715. This paper describes the binding of renin to the M-6-P receptor, provides the characteristics of prorenin binding on cardiac cells, and shows that internalized prorenin is activated by proteolytic cleavage.
Admiraal PJ, van Kesteren CA, Danser AHJ, et al.: Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J Hypertens 1999, 17:621–629.
Saris JJ, van den Eijnden MMED, Lamers JMJ, et al.: Prorenininduced myocyte proliferation: no role for intracellular angiotensin II. Hypertension 2002, 39:573–577. This interesting paper shows that prorenin alone has no functional effect on cardiac cells and confirms the absence of intracellular angiotensin generation. Cell-surface-generated Ang II binds and activates AT1 more efficiently than exogenous applied Ang II.
Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse ren-2d gene. Nature 1990, 344:541–544.
Peters J, Farrenkopf R, Clausmeyer S, et al.: Functional significance of prorenin internalization in the rat heart. Circ Res 2002, 90:1135–1141. An important paper that demonstrates the existence of another prorenin-binding protein and internalization pathway on cardiac cells, independent of the M-6-P receptor, not only in vitro but also in vivo. Accumulation of prorenin within cardiac cells and intracellular angiotensin generation revives the possibility of an intracrine angiotensin system.
Re RN: Implications of intracrine hormone action for physiology and medicine. Am J Physiol Heart Circ Physiol 2003, 284:H751-H757.
Bader M, Ganten D: It’s renin in the brain: transgenic animals elucidate the brain renin-angiotensin system. Circ Res 2002, 90:8–10.
Deinum J, Derkx FH, Danser AH, Schalekamp MA: Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990, 126:1673–1682.
Methot D, Silversides DW, Reudelhuber TL: In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res 1999, 84:1067–1072.
Prescott G, Silverside DW, Reudelhuber TL: Tissue activity of circulating prorenin. Am J Hypertens 2002, 13:280–285. Very interesting paper confirming prorenin uptake by cardiac tissue and supporting the existence of prorenin activity in tissue but not in the circulation.
Moravski CJ, Kelly DJ, Cooper ME, et al.: Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 2000, 36:1099–1044.
Véniant M, Ménard J, Bruneval P, et al.: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996, 98:1966–1970.
Hollenberg NK, Fischer NDL: Renal circulation and blockade of the renin-angiotensin system: Is angiotensin-converting enzyme inhibition the last word? Hypertension 1995, 26:602–609.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nguyen, G., Burcklé, C.A. & Sraer, JD. Renin/prorenin-receptor biochemistry and functional significance. Current Science Inc 6, 129–132 (2004). https://doi.org/10.1007/s11906-004-0088-3
Issue Date:
DOI: https://doi.org/10.1007/s11906-004-0088-3